Rhamy Zeid

Follow

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 12,157,735
- Issue date Dec 3, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 12,049,464
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 11,691,972
- Issue date Jul 4, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted protein degradation using a mutant E3 ubiquitin ligase
- Patent number 10,239,888
- Issue date Mar 26, 2019
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SELECTED COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20240245677
- Publication date Jul 25, 2024
- C4 Therapeutics, Inc.
- Katrina L. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20240051953
- Publication date Feb 15, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20230060334
- Publication date Mar 2, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20220098194
- Publication date Mar 31, 2022
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1
- Publication number 20210198256
- Publication date Jul 1, 2021
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED PROTEIN DEGRADATION USING A MUTANT E3 UBIQUITIN LIGASE
- Publication number 20180327419
- Publication date Nov 15, 2018
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE